Astragalus saponin IV promotes osteogenic differentiation of bone marrow mesenchymal stem cells via miR-21/NGF/BMP2/Runx2 pathway.

CONCLUSION: AS- IV might be used as a therapeutic agent for bone fracture or other orthopedic disorders.
PMID: 32381364 [PubMed - as supplied by publisher]

Source: Acta Histochemica - May 3, 2020 Category: Biochemistry Authors: Wu XH, Dou B, Sun NY, Gao J, Liu XL Tags: Acta Histochem Source Type: research